Non-Invasive Prenatal screening Test is an innovative genetic test for pregnant women at risk of foetal Patau syndrome (trisomy 13), Edwards’ syndrome (trisomy 18) or Down syndrome (trisomy 21).It can be performed with a single blood sample obtained from the mother from week 10 of pregnancy.Rapid, reliable and safe, NIPT is a screening option that enables detection of trisomies 13, 18 and 21 while limiting the required number of invasive tests (amniocentesis).
|Advantages of NIPT
|Detection rate of NIPT
||Single blood sample x 10mL
||Available from week 10 of pregnancy
||Results available within 7-10 business days
||Can minimize unnecessary invasive sampling by 95%
How does it work?
Besides maternal DNA, the blood of pregnant women contains foetal DNA originating from the placenta. The identification of this foetal DNA in the maternal blood, combined with the development of a new technology (Next Generation Sequencing) capable of counting all genetic material sequences in a maternal blood sample, makes it possible to determine whether a trisomy is present in the foetus.